IVY Cosmetics Adjusts Funding Expenditure Schedule Due to Middle East Tensions

TOKYO, Aug 05 (Pulse News Wire) – Ivy Cosmetics Corporation (4918.T) announced changes to the expenditure schedule for funds raised through the issuance of the fifth tranche of warrant shares, originally scheduled for August 6, 2024. The adjustments stem from delays in manufacturing and marketing plans for their 50th anniversary products due to heightened tensions in the Middle East.

Specifically, the company altered the timeline for several key expenditures related to product development and marketing. Originally planned for January to September 2026, the purchase of raw materials and manufacturing costs for the 50th anniversary products are now extended until March 2027.

Additionally, marketing expenses, initially set for April to September 2026, have also been pushed back to March 2027. The total amount raised from the warrant share issuance was higher than initially anticipated, totaling ¥368 million.

The funds will be allocated as follows: - Development institute enhancement and Labo department creation and operation funding: ¥0 - Exercise of the fifth tranche of warrant shares: ¥382 million - Issuance-related fees: ¥15 million Despite these changes, the company expects minimal impact on its current performance but will continue to monitor future implications and disclose any significant developments promptly.